Skip to main content

ResearchHubLoading navigation…

Loading ResearchHub…

Explore the network

Research, people, journals and institutions — all in one place.

Explore

01Research 02Smart search 03Researchers 04Journals 05Institutions 06RHR Rankings 07ResearchHub platform 08Events

Work together

Turn ideas into projects, questions and reusable datasets.

Connect

01Projects 02Questions 03Datasets

Stay informed

Follow trends, opportunities and your research library.

Insights

01Research trends 02Opportunities 03Library 04Research services 05ResearchHub Pro 06Pricing

ResearchHub

Explore ResearchHub.

Personal

01Recommended research 02Research intelligence

Home Search Network Library Log in

Cardio-Oncology - ResearchHub

ResearchHub

Research, connected

Explore the graph

X

Download ResearchHub

GET IT ONGoogle PlayComing soonDownload on theApp StoreComing soonEXPLORE IT ONAppGalleryComing soon

Research

Research Researchers Journals Institutions RHR Rankings

Contribute

Projects Questions Datasets Opportunities

Platform

ResearchHub platform About Blog Community Help API Licensing

Shopping

Contact and support

Need help, have a question, or want to contact the ResearchHub team?

Contact and support support@aresearch.uk

© 2026 ResearchHub. Built for responsible scholarly connection.

Help Article feed Privacy Terms Cookies This work is licensed under Creative Commons Attribution 4.0 InternationalCC BY 4.0

Privacy-aware community infrastructure

Privacy & Cookies

We use cookies and similar technologies

ResearchHub uses necessary technologies for security, authentication and core functionality. Advertising choices, where available, are collected separately through Google's consent message.

See our Privacy Notice and Cookie Policy.

Journal

Cardio-Oncology

2057-3804 · Springer Science and Business Media LLC

107 verified public works

Browse all journals →

Management of atrial fibrillation in patients taking targeted cancer therapies

2017 · 0 citations

Crizotinib inhibits hyperpolarization-activated cyclic nucleotide-gated channel 4 activity

2017 · 0 citations

Cardiovascular co-morbidity in cancer patients: the role of psychological distress

2016 · 0 citations

Juvenile competitive triathlete after cardiotoxic anthracycline therapy for Acute Myeloid Leukemia

2016 · 0 citations

A comparative assessment of coronary artery calcification on chest CT scans of patients referred to a cardio-oncology clinic

2016 · 0 citations

Persistent PR segment change in malignant pericardial disease

2016 · 0 citations

Rationale for setting up a cardio-oncology unit: our experience at Mayo Clinic

2016 · 0 citations

The interplay between genetic background and sexual dimorphism of doxorubicin-induced cardiotoxicity

2016 · 0 citations

Targeting endothelial cell metabolism for cardio-protection from the toxicity of antitumor agents

2016 · 0 citations

Doxorubicin cardiotoxicity and target cells: a broader perspective

2016 · 0 citations

Breast cancer treatment-associated cardiovascular toxicity and effects of exercise countermeasures

2016 · 0 citations

Tyrosine kinase inhibitor associated vascular toxicity in chronic myeloid leukemia

2015 · 0 citations

Hypertension in cancer patients treated with anti-angiogenic based regimens

2015 · 0 citations

Effect of myocardial dysfunction in cardiac morbidity and all cause mortality in childhood cancer subjects treated with anthracycline therapy

2015 · 0 citations

An Invitation from the Editors of Cardio-Oncology

2015 · 0 citations

Cardiac safety of afatinib: a review of data from clinical trials

2015 · 0 citations

Low dose radiation and circulatory diseases: a brief narrative review

2015 · 0 citations

PreviousPage 4 of 4